Science
Tuesday, 7/14, 10:34 PM
Experimental cell therapy shows early promise against deadly childhood brain cancer
- An early-stage trial of a genetically engineered immune therapy has shrunk tumors and extended survival in some children with diffuse midline glioma, one of the most lethal childhood cancers.
- Researchers stress the study is small and preliminary, and not a cure.